AKER stock news

The cost of floating wind farms is on a steeper decline than traditional offshore wind, making the emerging sector increasingly attractive to oil and gas companies, said Sebastian Bringsværd, head of floating wind development at Norwegian energy giant Equinor. After years of industry anticipation without a lot to show for it, the floating wind market is finally gaining momentum in a commercially meaningful way. The goal, Bringsværd said, is to scale floating projects up to a comparable level as traditional projects, which are often 500 megawatts or larger, taking advantage of offshore wind’s huge economies of scale. Just a few years ago that was an “ambitious” vision,” Bringsværd said. “Now I see that's very realistic.” Equinor, among Europe’s largest oil producers, carved out an early leadership position in the emerging floating wind sector, completing the industry’s first full-scale project several years ago, the 30-megawatt Hywind Scotland. ACS’ 50-megawatt Kincardine Bay floating project, also off the coast of Scotland, will go into operation later this year, setting a new industry benchmark. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(presented positive Phase 3 data for pimavanserin in dementia-related psychosis) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH )( reported positive readout for a pivotal trial in volcosporin for lupus nephritis) Bristol-Myers Squibb Co (NYSE: BMY ) Cassava Sciences Inc (NASDAQ: SAVA ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Incyte Corporation (NASDAQ: INCY ) Merck & Co., Inc. (NYSE: MRK ) Morphosys Ag (NASDAQ: MOR ) NuVasive, Inc. (NASDAQ: NUVA ) Oyster Point Pharma Inc (NASDAQ: OYST ) PTC Therapeutics, Inc. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) Allakos Inc (NASDAQ: ALLK )(announced exploration of strategic options, including a potential sale) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Bausch Health Companies Inc (NYSE: BHC ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Incyte Corporation (NASDAQ: INCY ) Inspire Medical Systems Inc (NYSE: INSP ) IVERIC bio Inc (NASDAQ: ISEE ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Kodiak Sciences Inc (NASDAQ: KOD ) Krystal Biotech Inc (NASDAQ: KRYS ) Merck & Co. Read more

Aker Drops After More Ghana Oil Delays

11:39am, Friday, 01'st Nov 2019
Billionaire Kjell Inge Rokke's Aker ASA dropped the most in 2 1/2 months after saying its oil venture in Ghana is facing more delays due to regulatory chal… Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 3) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Array Biopharma Inc (NASDAQ: ARRY ) Ascendis Pharma A/S (NASDAQ: ASND ) Mirati Therapeutics Inc (NASDAQ: MRTX )(reacted to ASCO presentation on a rival drug by Amgen, Inc. (NASDAQ: AMGN )) Misonix, Inc. (NASDAQ: MSON )(received FDA approval for its ultrasonic surgical platform) Trevi Therapeutics Inc (NASDAQ: TRVI ) (analyst began covering the stock after the IPO quiet period expiry ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 3) Arcus Biosciences Inc (NYSE: RCUS ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aduro BioTech Inc (NASDAQ: ADRO )(reacted to ASCO presentation on its Phase 1b data for ADU-S100) Akers Biosciences Inc (NASDAQ: AKER ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Celldex Therapeutics, Inc. (NASDAQ: CLDX )(reacted to ASCO presentation on CDX-3379) Cerus Corporation (NASDAQ: CERS ) ContraVir Pharmaceuticals (NASDAQ: CTRV )(began trading on a reverse split-adjusted basis) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) CytRx Corporation (NASDAQ: CYTR ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evogene Ltd … Read more

Akers Biosciences reports Q1 results

09:44pm, Monday, 20'th May 2019
Read more
The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Aker ASA OB:AKER is 2.367677. A lower price to book ratio indicates tha Read more
Akers Biosciences (AKER) shares are under scrutiny today as the Balance of Power has trended lower over multiple sessions. The Balance of Power is a simple indicator and it is used in technical analys Read more

Akers Biosciences reports FY results

09:37pm, Monday, 01'st Apr 2019
Read more

Akers Biosciences, Inc. files 10-K

09:16pm, Monday, 01'st Apr 2019
Akers Biosciences, Inc. revealed 10-K form on Apr 01, 2019 accessible here. PIFA ® Heparin/PF4 Rapid Assay and PIFA PLUSS ® PF4 remain the only FDA-cleared rapid manual assays that quickly determine Read more
The primary goal for some beginner traders might be just trying to survive. Traders that are disciplined with their money management may be able to better ride out the bumps that come with inexperienc Read more
Both Akers Biosciences Inc. (NASDAQ:AKER) and Becton Dickinson and Company (NYSE:BDX) are Medical Instruments & Supplies companies, competing one another. We will compare their risk, analyst recommend Read more
Bradley Foster & Sargent Inc decreased Lowes (LOW) stake by 2.63% reported in 2018Q4 SEC filing. Bradley Foster & Sargent Inc sold 3,544 shares as Lowes (LOW)’s stock rose 10.14%. The Bradley Foster Read more
Looking at the recent signals on shares of Akers Biosciences (AKER), we can see that the short-term MACD indicator is presently pointing to a Sell. The MACD is typically used to measure bullish or bea Read more
Needle moving action has been spotted in Akers Biosciences Inc (AKR.L) as shares are moving today on volatility -8.33% or -5.00 from the open. The LSE listed company saw a recent bid of 55.00 and 262 Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT